AMLX

Amylyx Pharmaceuticals, Inc.

18.70 USD
-0.01 (-0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Amylyx Pharmaceuticals, Inc. stock is up 18.5% since 30 days ago. The next earnings date is May 9, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
29 Feb 20:28 15 Mar, 2024 19.00 CALL 203 965
01 Mar 15:42 19 Apr, 2024 30.00 CALL 100 1389
01 Mar 15:51 17 Jan, 2025 22.50 CALL 117 110
01 Mar 16:20 17 May, 2024 30.00 CALL 80 422
01 Mar 17:33 21 Jun, 2024 20.00 CALL 100 10030
01 Mar 19:58 21 Jun, 2024 20.00 CALL 100 10030
01 Mar 19:58 21 Jun, 2024 20.00 CALL 100 10030
01 Mar 20:27 17 Jan, 2025 20.00 PUT 88 8
01 Mar 20:39 17 May, 2024 11.00 PUT 118 188
01 Mar 20:58 15 Mar, 2024 20.00 CALL 202 3158

About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product candidature includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid.